CONGRESSES
CONGRESSES
Find information on previous and upcoming congresses
View upcoming congresses and filter through abstracts, presentations, and posters from past congresses.
Upcoming congresses
2025 American Academy of Otolaryngic Allergy Congress
BioCryst will attend the 2025 American Academy of Otolaryngic Allergy Congress from Nov 14-16, 2025.
Browse our archive of congress materials
Filter
Showing 109 Materials
-
Emergency Department Experiences of Young Patients With Hereditary Angioedema and Their Caregivers (R117)
ACAAI | 2025 | HAE -
Burden of Attack for Young Patients With Hereditary Angioedema and Their Caregivers (R109)
ACAAI | 2025 | HAE -
Psychosocial Impact of Hereditary Angioedema on Young Patients and Their Caregivers (R102)
ACAAI | 2025 | HAE -
Hereditary Angioedema Attack Rates in Children 2–12 with Oral Prophylactic Berotralstat Over One Year
ACAAI | 2025 | HAE -
Suprachoroidal avoralstat, a plasma kallikrein inhibitor, stops vascular leakage in a well-established rabbit model
ASRS | 2025 | DME -
Burden of Treatment for Pediatric Patients (Aged Less Than 12 Years) With Hereditary Angioedema and Their Caregivers
HAEA National Summit | 2025 | HAE -
Patient Perspectives on the Importance of HAE Treatments
HAEA National Summit | 2025 | HAE -
HAE Attack Rates in Pediatric Patients 2 to <12 Years of Age with Prophylactic Berotralstat: Results from Interim Analysis of APeX-P
HAEA National Summit | 2025 | HAE -
Berotralstat Use Reduced Number of HAE Attacks Requiring Treatment or Professional Care in Pediatric Patients: Interim Results From APeX-P
EAACI | 2025 | HAE -
Assessment of the Effectiveness and Tolerability of Berotralstat for Long-term Prophylaxis in Hereditary Angioedema: Findings from the Berolife Study
EAACI | 2025 | HAE